Skip to content

Work in process at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$24.68M
Albemarle logo
AlbemarleALB
$312.7M+2.2%
Weyerhaeuser logo
WeyerhaeuserWY
$397M+36.4%
Pultegroup logo
PultegroupPHM
$4.08B
Essential Utilities logo
Essential UtilitiesWTRG
$415.53M+2.4%
Houlihan Lokey logo
Houlihan LokeyHLI
-$35.46M-169%

Other financials

Income statement

See full
Revenue$1.1B-4.0%
Gross profit$363.2M-5.8%
Operating income$180.3M-1.8%
Net income$127.7M-10.9%
EPS (diluted)$3.10-3.1%

Balance sheet

See full
Cash & equivalents$771.3M+250%
Total debt$2.9B+52.5%
Total equity$1.7B-23.7%
Total assets$6.0B+9.9%

Cash flow

See full
Operating cash flow-$44.7M-2,583%
CapEx$28.3M-2.4%
Free cash flow-$73.0M-168%

Valuation

See full
Market cap$14.61B-9.3%
Enterprise value$16.72B-5.7%
P/E20.1×+7.4×
P/S2.9×-0.3×

Profitability

See full
Gross margin35.6%-1.9pp
Operating margin20.1%-1.9pp
Net margin14.6%-10.7pp
FCF margin18.6%+3.4pp

Returns & leverage

See full
Return on equity38%-12.3pp
Debt / equity1.7×+0.9×
Current ratio3.4×+0.8×

Where this comes from

Reported directly by Carlisle Companies in its filing.

Tagged under the XBRL concept us-gaap:InventoryWorkInProcess.

The official record: Carlisle Companies’s 10-Q, filed April 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Carlisle Companies's work in process.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Carlisle Companies's work in process?
Carlisle Companies (CSL) reported work in process of $29.8M in Q1 2026.
How has Carlisle Companies's work in process changed year-over-year?
Carlisle Companies's work in process increased by 13.3% year-over-year, from $26.3M to $29.8M.
What is the long-term trend for Carlisle Companies's work in process?
Over 5 years (2020 to 2025), Carlisle Companies's work in process has grown at a -17.9% compound annual growth rate (CAGR), from $67.4M to $25.1M.